Proffitt & Goodson’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History

Proffitt & Goodson’s Portfolio CELGZ Stock Details CELGZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-500	Closed	–	–	231
2019 Q3	$0	Buy	+500	New	+$279	﹤0.01%	224

Proffitt & Goodson's CELGZ Position: Q4 2019 in Review

Proffitt & Goodson sold out of Celgene Corporation Contingent Value Rights (CELGZ) in Q4 2019, closing a stake of 500 shares.

Proffitt & Goodson first reported a position in CELGZ in Q3 2019 and held it in 1 quarter. The position peaked at $0 in Q3 2019. 0 funds tracked by Wall St. Rank hold CELGZ as of Q4 2019.

Proffitt & Goodson reported no remaining Celgene Corporation Contingent Value Rights position as of Q4 2019 after selling out during the quarter.
Proffitt & Goodson sold 500 Celgene Corporation Contingent Value Rights shares in Q4 2019.
Proffitt & Goodson first reported a position in Celgene Corporation Contingent Value Rights in Q3 2019 and held it in 1 quarter.
Proffitt & Goodson's Celgene Corporation Contingent Value Rights position peaked at $0 in Q3 2019.
0 funds tracked by Wall St. Rank held Celgene Corporation Contingent Value Rights as of Q4 2019.

Based on Proffitt & Goodson's 13F filing for Q4 2019, filed 29 Jan 2020.